Skip to main content

Table 2 RASSF1A and MAL methylation frequencies in the breast carcinoma samples as determined by MS-HRM

From: No evidence for promoter region methylation of the succinate dehydrogenase and fumarate hydratase tumour suppressor genes in breast cancer

  RASSF1A Positive RASSF1A Negative Total
MAL Positive 28 (38.9%) 2 (2.8%) 30 (41.7%)
MAL Negative 32 (44.4%) 10 (13.9%) 42 (58.3%)
Total 60 (83.3%) 12 (16.7%) 72